{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:21:03Z","timestamp":1791105663770,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.expneurol.2003.09.001","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T09:21:42Z","timestamp":1068196902000},"page":"36-46","source":"Crossref","is-referenced-by-count":67,"title":["Ropinirole versus l-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia"],"prefix":"10.1016","volume":"185","author":[{"given":"Paula","family":"Ravenscroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brotchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2003.09.001_BIB1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1471-4159.1992.tb09368.x","article-title":"Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain","volume":"58","author":"Angulo","year":"1992","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/377424a0","article-title":"Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors","volume":"377","author":"Baik","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB3","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/(SICI)1098-2396(199902)31:2<134::AID-SYN6>3.0.CO;2-V","article-title":"Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease","volume":"31","author":"Chalon","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB5","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.bjp.0702673","article-title":"Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells","volume":"127","author":"Coldwell","year":"1999","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB6","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1073\/pnas.91.20.9631","article-title":"6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons","volume":"91","author":"Cole","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0896-6273(95)90225-2","article-title":"Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum","volume":"14","author":"Cole","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB8","doi-asserted-by":"crossref","first-page":"12564","DOI":"10.1073\/pnas.91.26.12564","article-title":"Altered striatal function in a mutant mouse lacking D1A dopamine receptors","volume":"91","author":"Drago","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0306-4522(96)00145-5","article-title":"D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum","volume":"74","author":"Drago","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0306-4522(90)90399-O","article-title":"D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons","volume":"37","author":"Dragunow","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/exnr.1997.6431","article-title":"Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression","volume":"144","author":"Duty","year":"1997","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/exnr.1997.6771","article-title":"Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat","volume":"150","author":"Duty","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0091-3057(91)90603-Y","article-title":"Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist","volume":"38","author":"Eden","year":"1991","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(91)90667-K","article-title":"Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats","volume":"552","author":"Engber","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0091-3057(00)00305-1","article-title":"Effects of ropinirole on motor behavior in MPTP-treated common marmosets","volume":"67","author":"Fukuzaki","year":"2000","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0091-3057(99)00240-3","article-title":"Effects of ropinirole on various parkinsonian models in mice, rats, and cynomolgus monkeys","volume":"65","author":"Fukuzaki","year":"2000","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","article-title":"Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis","volume":"11","author":"Gerfen","year":"1991","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB19","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1523\/JNEUROSCI.15-12-08167.1995","article-title":"D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons","volume":"15","author":"Gerfen","year":"1995","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01271237","article-title":"Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion","volume":"103","author":"Granata","year":"1996","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/exnr.2000.7555","article-title":"Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment","volume":"167","author":"Harrison","year":"2001","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated l-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/exnr.2001.7727","article-title":"Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"171","author":"Henry","year":"2001","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(96)00229-1","article-title":"Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum","volume":"75","author":"Huang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling","volume":"80","author":"Hunter","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0169-328X(92)90108-N","article-title":"Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum","volume":"15","author":"Jaber","year":"1992","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0169-328X(94)90206-2","article-title":"Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary","volume":"23","author":"Jaber","year":"1994","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0169-328X(95)00064-Y","article-title":"Effect of reserpine treatment on enkephalin mRNA level in the rat striatum: an in situ hybridization study","volume":"32","author":"Jaber","year":"1995","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0143-4179(95)90093-4","article-title":"Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum","volume":"29","author":"Jolkkonen","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB31","doi-asserted-by":"crossref","first-page":"PL159, PL170","DOI":"10.1016\/0024-3205(96)00021-5","article-title":"Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat","volume":"58","author":"Kashihara","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB32","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1523\/JNEUROSCI.14-09-05623.1994","article-title":"Amphetamine regulates gene expression in rat striatum via transcription factor CREB","volume":"14","author":"Konradi","year":"1994","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","article-title":"The organization of the projection from the cerebral cortex to the striatum in the rat","volume":"29","author":"McGeorge","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-328X(97)00123-X","article-title":"Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy","volume":"49","author":"Morissette","year":"1997","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(95)00924-3","article-title":"Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade","volume":"701","author":"Papa","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB38","first-page":"73","article-title":"Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys","volume":"69","author":"Parent","year":"1996","journal-title":"Adv. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB39","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.870130207","article-title":"De novo administration of ropinirole and bromocriptine induces less dyskinesia than l-dopa in the MPTP-treated marmoset","volume":"13","author":"Pearce","year":"1998","journal-title":"Mov. Disord"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s007020070029","article-title":"Comparative effects of repeated administration of dopamine agonists on circling behavior in rats","volume":"107","author":"Prikhojan","year":"2000","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB42","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1211\/0022357001774895","article-title":"Comparative pharmacological study of ropinirole (SKF-101468) and its metabolites in rats","volume":"52","author":"Reavill","year":"2000","journal-title":"J. Pharm. Pharmacol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0306-4522(92)90054-6","article-title":"Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine","volume":"46","author":"Robertson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0006-8993(90)91498-6","article-title":"Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos","volume":"523","author":"Robertson","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0306-4522(92)90096-K","article-title":"D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons","volume":"49","author":"Robertson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002210050545","article-title":"Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior","volume":"123","author":"Steiner","year":"1998","journal-title":"Exp. Brain Res"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0306-4522(98)00241-3","article-title":"Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons","volume":"88","author":"Steiner","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(92)90295-F","article-title":"Effects of a unilateral 6-hydroxydopamine lesion and prolonged l-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia","volume":"219","author":"Taylor","year":"1992","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB50","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1212\/WNL.49.1_Suppl_1.S58","article-title":"Pharmacologic profile of ropinirole: a nonergoline dopamine agonist","volume":"49","author":"Tulloch","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(94)90557-6","article-title":"Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses","volume":"79","author":"Xu","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2003.09.001_BIB53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0306-4522(94)00574-O","article-title":"Chronic l-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat","volume":"66","author":"Zeng","year":"1995","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488603004424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488603004424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T13:09:26Z","timestamp":1585228166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488603004424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0014488603004424"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2003.09.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}